common side effects of doxil
severe anemia
severe erythrodysesthesia syndrome
nausea
vomiting
diarrhea
stomatitis
erythrodysesthesia syndrome
alopecia
anemia
asthenia
bone marrow depression
neutropenia
thrombocytopenia
anorexia
other side effects
asthma
syncope
severe neutropenia
pain
chest pain
dyspnea
facial edema
fever
headache
hypotension
pruritus
skin rash
tachycardia
pharyngitis
chills
comprehensive list of adverse effects
following side effects
taking doxorubicin
doctor
nurse
myelosuppression
palmar-plantar erythrodysesthesia
hand-foot syndrome
stomatitis
cardiac toxicity
infusion-related reactions
major dose-limiting toxicities of doxorubicin
active ingredient
doxil
side effects
section
most part
clinical trials with ovarian cancer patients
n =-rrb-
trials with aids-related kaposi
sarcoma patients
n =-rrb-
causality
aids patients
underlying disease
concurrent drug therapy
cardiovascular effects
kaposi
sarcoma patients
doxorubicin
active ingredient
doxil
cases of cardiomyopathy
congestive heart failure
severe events
arrhythmia
cardiomyopathy
heart failure
pericardial effusion
tachycardia
other cardiac side effects
chest pain
hypotension
patients
other reported effects
hypertension
angina pectoris
postural hypotension
palpitations
syncope
shock
bradycardia
phlebitis
cardiomegaly
thrombophlebitis
hemorrhage
palpitation
syncope
bundle branch block
cardiac arrest
thrombosis
ventricular arrhythmia in less
cardiovascular
side effects of conventional doxorubicin
congestive heart failure
development of left ventricular
lv
systolic dysfunction
patients
retrospective data
incidence of clinical heart failure in patients
preexisting lv
systolic dysfunction
ejection fraction
lvef
decline
absolute lvef
least mg/m cumulative dose
data
shown right ventricular septal wall motion
lv
diastolic dysfunction
development of doxorubicin-induced lv
systolic dysfunction
early effects of anthracyclines
rare cases of pericarditis-myocarditis
patients with no prior history of cardiac disease
high mortality rate
ventricular dysfunction
significant heart failure in patients with limited cardiac reserve
arrhythmias
sinus tachycardia
rhythm disturbances
acute administration
clinical importance
isolated cases of symptomatic supraventricular tachycardia
heart block
ventricular arrhythmias
risk of heart failure
total doses of mg/m
history of prior radiation therapy
heart
area
use of other
cardiotoxic agents
cyclophosphamide
doxorubicin-induced heart failure
month
year
termination of therapy
late cardiomyopathy
patients
doxorubicin as a child
prevention
cumulative dose limitation
earlier diagnosis
radionuclide angiocardiography
echocardiography
alterations in the schedule of administration
substitution of prolonged
infusion for bolus injection
development of less cardiotoxic anthracyclines
use of cardioprotectors
dexrazoxane
treatment of doxorubicin-induced heart failure
traditional therapy with rest
digitalis
diuretics
angiotensin converting enzyme
ace
inhibitors
reliable marker
patients
doxorubicin-induced heart failure
serial
noninvasive testing of lv function
radionuclide angiocardiography
echocardiography
ecg
limited value
recent data
plasma endothelin
atrial natriuretic peptide levels
predicting
risk of cardiotoxicity
drug
endomyocardial biopsy
definitive evaluation of risk
limited animal data
vitamins
e
adenosine
q
n-acetylcysteine
methylene blue
incidence of doxorubicin-induced cardiotoxicity
benefits of doxorubicin
risks in patients with a demonstrable decrease in cardiac function
hematologic side effects
dose-dependent myelosuppression
anemia
neutropenia
leukopenia
thrombocytopenia
hematologic events
ovarian cancer trials
leukopenia
mm
mm
cytokine support
neutropenia
mm
mm
febrile neutropenia
anemia
< g/dl
< g/dl
rbc transfusions
epoetin alpha support
thrombocytopenia
mm
mm
platelet transfusions
hypochromic anemia
ecchymosis
petechiae
side effects
kaposi
sarcoma trials
anemia
hypochromic anemia
thrombocytopenia
hemolysis
prothrombin time
eosinophilia
petechiae
thromboplastin
leukocyte count
nadir
days after treatment
persistent myelosuppression
superinfection
hemorrhage
gcsf
dose reductions
interruptions in dose schedules
single case of acute hemolytic anemia
administration of doxorubicin
patient with glucose
phosphate dehydrogenase
gpd
deficiency
drug
reactive oxygen compounds
methemoglobin in normal human red blood cells
rbcs
rbcs
gpd doxorubicin
potent oxidant stress
patients with gpd
hemolysis
receiving doxorubicin
secondary acute myelogenous leukemia
patients
topoisomerase
inhibitors
including anthracyclines
scalp tourniquet
scalp cooling
doxorubicin-induced alopecia
doxorubicin
diseases
scalp
reservoir for disease
i.
e.
lymphoma
leukemia
dermatologic side effects
clinical trials
palmar-plantar erythrodysesthesia
hand-foot syndrome
grades
grade
ovarian cancer patients
rash
alopecia
dry skin
pruritus
skin discoloration
skin disorders
herpes simplex
vesiculobullous rash
maculopapular rash
exfoliative dermatitis
herpes zoster
sweating
skin ulcers
skin ulcer
skin discoloration
cutaneous moniliasis
erythema multiforme
erythema nodosum
furunculosis
psoriasis
pustular rash
skin necrosis
urticaria
herpes simplex
contact dermatitis
fungal dermatitis
skin nodules
urticaria
acne
gastrointestinal side effects
ovarian cancer trials
stomatitis
grades
grade
nausea
grades
grade
vomiting
constipation
anorexia
diarrhea
abdominal pain
dyspepsia
oral moniliasis
mouth ulceration
esophagitis
dysphagia
patients
gingivitis
eructation
salivation
melena
gastrointestinal hemorrhage
proctitis
jaundice
ileus
periodontal abscess
flatulence
aphthous stomatitis
gastritis
glossitis
gum hemorrhage
side effects
kaposi
sarcoma trials
nausea
vomiting
diarrhea
stomatitis
oral moniliasis
mouth ulceration
glossitis
constipation
aphthous stomatitis
anorexia
dysphagia
abdominal pain
dyspepsia
gastritis
gingivitis
ulcerative proctitis
colitis
esophageal ulcer
esophagitis
gastrointestinal hemorrhage
oral leukoplakia
pancreatitis
ulcerative stomatitis
appetite
sclerosing cholangitis
tenesmus
fecal impaction
nausea
vomiting
appropriate antiemetic therapy
stomatitis
other ulcerations
days after administration
bleeding
local infection
severe cases of colonic ulceration
hypersensitivity side effects
acute infusion-associated reactions
flushing
shortness of breath
facial swelling
headache
chills
pain
tightness in the chest
throat
hypotension
patients
doxorubicin
active ingredient
doxil
other side effects
unspecified allergic reactions
anaphylactoid reaction
renal side effects
rare cases of new
worsened renal insufficiency
single case
progressive glomerulonephritis without evidence of a secondary cause
immunologic mechanism
albuminuria
kaposi
sarcoma patients
creatinine elevations
abnormal kidney function
hydronephrosis
hematuria
glycosuria
bun
kidney failure
renal insufficiency
doxorubicin-induced hyperuricemia
cell lysis
adequate hydration
diuresis
allopurinol
animal data
doxorubicin
glomerular basement membrane injury via production of reactive oxygen species
administration of some antioxidants
urinary excretion of lysozyme
n-acetyl-glucosaminidase
markers of tubule injury
treated animals
other side effects of doxorubicin
predisposition of patients
received radiation therapy
xrt
recall
phenomenon
radiation pneumonitis
esophagitis
combination of doxorubicin
xrt
xrt
xrt
heart/mediastinum
risk of doxorubicin-induced cardiomyopathy
endomyocardial biopsy data
cellular morphological changes in patients
doxorubicin
mediastinal xrt
treated patients without a history of cardiac
mediastinal xrt
mediastinal xrt
higher risk of doxorubicin-induced cardiomyopathy
oncologic side effects
secondary leukemia
prior exposure
doxorubicin
single case of skin cancer
site of doxorubicin extravasation years
ocular side effects
conjunctivitis
retinitis
amblyopia
blepharitis
abnormal vision
blindness
conjunctivitis
eye pain
optic neuritis
visual field defect
genitourinary side effects
ovarian cancer trials
urinary tract infection
leukorrhea
cystitis
nocturia
breast pain
mastitis
oliguria
vaginitis
vaginal hemorrhage
vaginal moniliasis in less
side effects
kaposi
sarcoma trials
balanitis
cystitis
dysuria
genital edema in less
musculoskeletal side effects
myalgia
patients
arthralgia
bone pain
myositis
myasthenia in less
nervous system
side effects
asthenia
kaposi
sarcoma patients
paresthesia
ovarian cancer patients
pain
ovarian cancer patients
headache
dizziness
emotional lability
somnolence
depression
insomnia
anxiety
peripheral neuritis
incoordination
abnormal thinking
paresthesia
confusion
neuropathy
convulsion
hypotonia
hypertonia
acute brain syndrome
nervousness
migraine
vertigo
hypokinesia
hyperesthesia
hypesthesia
hemiplegia
neuropathy
ataxia
respiratory side effects
pharyngitis
ovarian cancer patients
dyspnea
cough
rhinitis
pleural effusion
asthma
hiccup
pneumothorax
bronchitis
hyperventilation
laryngitis
pneumothorax
sinusitis
voice alteration
epistaxis
pneumonia
metabolic side effects
increased alkaline phosphatase
kaposi
sarcoma patients
peripheral edema
generalized edema
dehydration
hypercalcemia
hypocalcemia
hyperglycemia
hypoglycemia
hyperkalemia
hypokalemia
hypermagnesemia
hypomagnesemia
hypernatremia
hyponatremia
weight gain
weight loss
cachexia
increased lactic dehydrogenase
dehydration
hyperlipidemia
hypolipidemia
hyperuricemia
hypophosphatemia
hypoproteinemia
ketosis
hypochloremia
hepatic side effects
clinical trials
sgpt increase
hyperbilirubinemia
sgot elevations
cholestatic jaundice
hepatic failure
hepatitis
jaundice
side effects
special senses
taste perversion
parosmia
taste loss
otitis media
tinnitus
loss of the sense of taste
side effects
ovarian cancer trials
mucous membrane disorder
fever
chills
infection
chest pain
pain
enlarged abdomen
malaise
cellulitis
ascites
flu syndrome
neck pain
moniliasis
facial edema
chills
fever
pelvic pain
substernal chest pain
side effects
kaposi
sarcoma trials
pain
infection
chills
facial edema
cellulitis
sepsis
abscess
radiation injury
flu syndrome
moniliasis
hypothermia
cryptococcosis
ascites
local side effects
injection site pain
injection site hemorrhage
inflammation in less
patients
endocrine side effects
diabetes mellitus in less
black, tarry stools
blistering
peeling
redness
swelling of the palms of the hands
bottoms of the feet
blood in the urine
stools
chills
cough or hoarseness
facial swelling
fever
headache
loss of strength
energy
side pain
numbness
pain
tingling
unusual sensations in the palms of the hands
bottoms of the feet
difficult urination
red spots on the skin
shortness of breath
sore throat
sores in the mouth
lips
unusual bleeding
bruising
unusual tiredness
weakness
pain at the injection site
skin rash
itching
chest pain
decreased urine output
dilated neck veins
extreme fatigue
irregular breathing
irregular heartbeat
swelling of the face
fingers
feet
lower legs
tightness in the chest
weight gain
yellowing of the eyes
skin
curd-like patches in mouth
throat
diarrhea
loss of appetite
nausea
pain
eating
swallowing
sore throat
swallowing problems
vomiting
anxiety
back pain
unpleasant aftertaste
burning
itching eyes
change in skin color
constipation
dizziness
excessive tearing
itching
joint pain
muscle aches
redness
pain
swelling of the eye
eyelid
inner lining of the eyelid
trouble sleeping
abnormal thinking
change in sense of smell
chills
clumsiness
unsteadiness
trembling
problems with muscle coordination
cough
fever
general feeling of discomfort
illness
shivering
sweating